| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Vera Therapeutics, Inc. (VERA) have been net sellers, shedding 37,000 shares worth roughly $1.3M on balance.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 235.2K | $7.22M | - | |
| CFO | 114.2K | $3.51M | - | |
| VP | 80.8K | $2.48M | - | |
| Other | 64.2K | $1.97M | - | |
| Other | 50.9K | $1.56M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 6, 2022 | Sean Grant56 | Chief Financial Officer | Buy | 14,285 | $7.00 | $99,995.00 | +40.1% | -9.1% | -65.8% | |
| May 18, 2021 | Maha Katabi71 | Director, 10% Owner | Buy | 727,272 | $11.00 | $7,999,992.00 | +33.2% | +37.7% | +32.9% | |
| May 18, 2021 | Patrick G Enright71 | Director, 10% Owner | Buy | 909,090 | $11.00 | $9,999,990.00 | +41.6% | +37.7% | +32.9% | |
| May 18, 2021 | Longitude Capital Partners IV, LLC63 | 10% Owner | Buy | 909,090 | $11.00 | $9,999,990.00 | +41.6% | +37.7% | +32.9% | |
| May 18, 2021 | Sofinnova Venture Partners X, L.P.55 | 10% Owner | Buy | 727,272 | $11.00 | $7,999,992.00 | +33.2% | +37.7% | +32.9% | |
| May 18, 2021 | Kurt Von Emster62 | Director | Buy | 790,555 | $11.02 | $8,714,653.25 | +36.4% | +37.7% | +32.9% | |
| May 18, 2021 | Abingworth LLP | 10% Owner | Buy | 772,727 | $11.00 | $8,499,997.00 | +35.3% | +37.7% | +32.9% |